You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

List of Excipients in API diclofenac epolamine


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing diclofenac epolamine

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Teva Pharmaceuticals USA Inc DICLOFENAC EPOLAMINE diclofenac epolamine 0093-3225 BUTYLENE GLYCOL
Teva Pharmaceuticals USA Inc DICLOFENAC EPOLAMINE diclofenac epolamine 0093-3225 CARBOXYMETHYLCELLULOSE SODIUM
Teva Pharmaceuticals USA Inc DICLOFENAC EPOLAMINE diclofenac epolamine 0093-3225 DIHYDROXYALUMINUM AMINOACETATE
Teva Pharmaceuticals USA Inc DICLOFENAC EPOLAMINE diclofenac epolamine 0093-3225 EDETATE DISODIUM
Teva Pharmaceuticals USA Inc DICLOFENAC EPOLAMINE diclofenac epolamine 0093-3225 GELATIN
Teva Pharmaceuticals USA Inc DICLOFENAC EPOLAMINE diclofenac epolamine 0093-3225 KAOLIN
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Subscribe

Excipients in ANDA-approved (generic) drugs containing diclofenac epolamine

Company Ingredient NDC Excipient
Physicians Total Care Inc diclofenac epolamine 54868-5962 BUTYLENE GLYCOL
Physicians Total Care Inc diclofenac epolamine 54868-5962 CARBOXYMETHYLCELLULOSE SODIUM
Physicians Total Care Inc diclofenac epolamine 54868-5962 DIHYDROXYALUMINUM AMINOACETATE
Physicians Total Care Inc diclofenac epolamine 54868-5962 EDETATE DISODIUM
Physicians Total Care Inc diclofenac epolamine 54868-5962 GELATIN
Physicians Total Care Inc diclofenac epolamine 54868-5962 KAOLIN
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Subscribe

Detailed excipient profiles for diclofenac epolamine

Excipient focus: BUTYLENE GLYCOL

Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM

diclofenac epolamine drug variants containing CARBOXYMETHYLCELLULOSE SODIUM

Company Ingredient NDC
Teva Pharmaceuticals USA Inc diclofenac epolamine 0093-3225
Teva Pharmaceuticals USA Inc diclofenac epolamine 0093-3727
Rebel Distributors Corp diclofenac epolamine 21695-707
Rebel Distributors Corp diclofenac epolamine 42254-248
STAT Rx USA LLC diclofenac epolamine 42549-606
A-S Medication Solutions diclofenac epolamine 50090-1195
>Company >Ingredient >NDC

Subscribe to access the full database, or Subscribe

Excipient focus: DIHYDROXYALUMINUM AMINOACETATE

diclofenac epolamine drug variants containing DIHYDROXYALUMINUM AMINOACETATE

Company Ingredient NDC
Teva Pharmaceuticals USA Inc diclofenac epolamine 0093-3225
Teva Pharmaceuticals USA Inc diclofenac epolamine 0093-3727
Rebel Distributors Corp diclofenac epolamine 21695-707
Rebel Distributors Corp diclofenac epolamine 42254-248
STAT Rx USA LLC diclofenac epolamine 42549-606
A-S Medication Solutions diclofenac epolamine 50090-1195
>Company >Ingredient >NDC

Subscribe to access the full database, or Subscribe

Excipient focus: EDETATE DISODIUM

Excipient focus: GELATIN

Excipient focus: HEPARIN SODIUM

diclofenac epolamine drug variants not containing HEPARIN SODIUM

Company Ingredient NDC
Teva Pharmaceuticals USA Inc diclofenac epolamine 0093-3225
Teva Pharmaceuticals USA Inc diclofenac epolamine 0093-3727
Rebel Distributors Corp diclofenac epolamine 21695-707
Rebel Distributors Corp diclofenac epolamine 42254-248
STAT Rx USA LLC diclofenac epolamine 42549-606
A-S Medication Solutions diclofenac epolamine 50090-1195
>Company >Ingredient >NDC

Subscribe to access the full database, or Subscribe

Excipient focus: KAOLIN

Excipient focus: METHYLPARABEN

Excipient focus: POLYSORBATE 80

Excipient focus: POVIDONE

Excipient focus: POVIDONES

Excipient focus: PROPYLENE GLYCOL

Excipient focus: PROPYLPARABEN

Excipient focus: SORBITOL

Excipient focus: TARTARIC ACID

Excipient focus: TITANIUM DIOXIDE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group